vs
Southland Holdings, Inc.（SLND）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Southland Holdings, Inc.的1.2倍（$127.1M vs $104.0M），再鼎医药同比增速更快（17.1% vs -61.1%），Southland Holdings, Inc.自由现金流更多（$9.3M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -39.9%）
Southland Holdings, Inc.是北美知名基础设施建设企业，主营公路、桥梁、机场等交通工程、水处理系统搭建及商业场地开发业务，服务公共部门及私营领域客户，业务覆盖北美核心市场。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
SLND vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.2倍
$104.0M
营收增速更快
ZLAB
高出78.2%
-61.1%
自由现金流更多
SLND
多$36.0M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-39.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.0M | $127.1M |
| 净利润 | $-216.4M | — |
| 毛利率 | -186.0% | 51.0% |
| 营业利润率 | -202.4% | -54.6% |
| 净利率 | -208.2% | — |
| 营收同比 | -61.1% | 17.1% |
| 净利润同比 | -5108.5% | — |
| 每股收益（稀释后） | $-4.01 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLNDZLAB
| Q4 25 | $104.0M | $127.1M | ||
| Q3 25 | $213.3M | $115.4M | ||
| Q2 25 | $215.4M | $109.1M | ||
| Q1 25 | $239.5M | $105.7M | ||
| Q4 24 | $267.3M | $108.5M | ||
| Q3 24 | $173.3M | $101.8M | ||
| Q2 24 | $251.5M | $100.1M | ||
| Q1 24 | $288.1M | $87.1M |
净利润SLNDZLAB
| Q4 25 | $-216.4M | — | ||
| Q3 25 | $-75.3M | $-36.0M | ||
| Q2 25 | $-10.3M | $-40.7M | ||
| Q1 25 | $-4.6M | $-48.4M | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-54.7M | $-41.7M | ||
| Q2 24 | $-46.1M | $-80.3M | ||
| Q1 24 | $-406.0K | $-53.5M |
毛利率SLNDZLAB
| Q4 25 | -186.0% | 51.0% | ||
| Q3 25 | 1.5% | 59.5% | ||
| Q2 25 | 6.2% | 60.6% | ||
| Q1 25 | 9.0% | 63.6% | ||
| Q4 24 | 2.9% | 61.5% | ||
| Q3 24 | -29.5% | 64.1% | ||
| Q2 24 | -15.9% | 64.9% | ||
| Q1 24 | 7.1% | 61.4% |
营业利润率SLNDZLAB
| Q4 25 | -202.4% | -54.6% | ||
| Q3 25 | -5.3% | -42.3% | ||
| Q2 25 | -0.1% | -50.3% | ||
| Q1 25 | 2.1% | -53.3% | ||
| Q4 24 | -3.0% | -62.6% | ||
| Q3 24 | -39.6% | -66.6% | ||
| Q2 24 | -22.1% | -76.0% | ||
| Q1 24 | 2.1% | -80.7% |
净利率SLNDZLAB
| Q4 25 | -208.2% | — | ||
| Q3 25 | -35.3% | -31.2% | ||
| Q2 25 | -4.8% | -37.3% | ||
| Q1 25 | -1.9% | -45.8% | ||
| Q4 24 | -1.6% | — | ||
| Q3 24 | -31.6% | -40.9% | ||
| Q2 24 | -18.3% | -80.2% | ||
| Q1 24 | -0.1% | -61.4% |
每股收益（稀释后）SLNDZLAB
| Q4 25 | $-4.01 | $-0.05 | ||
| Q3 25 | $-1.39 | $-0.03 | ||
| Q2 25 | $-0.19 | $-0.04 | ||
| Q1 25 | $-0.08 | $-0.04 | ||
| Q4 24 | $-0.08 | $-0.09 | ||
| Q3 24 | $-1.14 | $-0.04 | ||
| Q2 24 | $-0.96 | $-0.08 | ||
| Q1 24 | $-0.01 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.7M | $689.6M |
| 总债务越低越好 | $257.7M | — |
| 股东权益账面价值 | $-140.9M | $715.5M |
| 总资产 | $989.3M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SLNDZLAB
| Q4 25 | $52.7M | $689.6M | ||
| Q3 25 | $40.5M | $717.2M | ||
| Q2 25 | $46.5M | $732.2M | ||
| Q1 25 | $65.1M | $757.3M | ||
| Q4 24 | $72.2M | $779.7M | ||
| Q3 24 | $91.4M | $616.1M | ||
| Q2 24 | $52.4M | $630.0M | ||
| Q1 24 | $31.2M | $650.8M |
总债务SLNDZLAB
| Q4 25 | $257.7M | — | ||
| Q3 25 | $267.8M | — | ||
| Q2 25 | $278.6M | — | ||
| Q1 25 | $288.1M | — | ||
| Q4 24 | $300.1M | — | ||
| Q3 24 | $318.3M | — | ||
| Q2 24 | $307.8M | — | ||
| Q1 24 | $302.0M | — |
股东权益SLNDZLAB
| Q4 25 | $-140.9M | $715.5M | ||
| Q3 25 | $75.0M | $759.9M | ||
| Q2 25 | $151.1M | $791.7M | ||
| Q1 25 | $159.1M | $810.8M | ||
| Q4 24 | $163.7M | $840.9M | ||
| Q3 24 | $149.1M | $667.7M | ||
| Q2 24 | $203.3M | $704.2M | ||
| Q1 24 | $249.3M | $762.2M |
总资产SLNDZLAB
| Q4 25 | $989.3M | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.2B | $985.3M | ||
| Q2 24 | $1.3B | $987.4M | ||
| Q1 24 | $1.2B | $988.4M |
负债/权益比SLNDZLAB
| Q4 25 | — | — | ||
| Q3 25 | 3.57× | — | ||
| Q2 25 | 1.84× | — | ||
| Q1 25 | 1.81× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 1.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.7M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $9.3M | $-26.7M |
| 自由现金流率自由现金流/营收 | 8.9% | -21.0% |
| 资本支出强度资本支出/营收 | 0.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $12.7M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流SLNDZLAB
| Q4 25 | $9.7M | $-26.0M | ||
| Q3 25 | $5.9M | $-32.0M | ||
| Q2 25 | $-5.4M | $-31.0M | ||
| Q1 25 | $6.4M | $-61.7M | ||
| Q4 24 | $-10.3M | $-55.8M | ||
| Q3 24 | $-5.3M | $-26.8M | ||
| Q2 24 | $27.4M | $-42.2M | ||
| Q1 24 | $-9.9M | $-90.1M |
自由现金流SLNDZLAB
| Q4 25 | $9.3M | $-26.7M | ||
| Q3 25 | $5.3M | $-35.0M | ||
| Q2 25 | $-6.5M | $-33.9M | ||
| Q1 25 | $4.6M | $-63.2M | ||
| Q4 24 | $-11.5M | $-58.4M | ||
| Q3 24 | $-7.3M | $-28.2M | ||
| Q2 24 | $26.3M | $-42.9M | ||
| Q1 24 | $-13.0M | $-91.1M |
自由现金流率SLNDZLAB
| Q4 25 | 8.9% | -21.0% | ||
| Q3 25 | 2.5% | -30.4% | ||
| Q2 25 | -3.0% | -31.1% | ||
| Q1 25 | 1.9% | -59.9% | ||
| Q4 24 | -4.3% | -53.8% | ||
| Q3 24 | -4.2% | -27.7% | ||
| Q2 24 | 10.5% | -42.9% | ||
| Q1 24 | -4.5% | -104.5% |
资本支出强度SLNDZLAB
| Q4 25 | 0.4% | 0.5% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.5% | 2.6% | ||
| Q1 25 | 0.7% | 1.5% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 1.1% | 1.3% | ||
| Q2 24 | 0.4% | 0.7% | ||
| Q1 24 | 1.1% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SLND
| Civil | $58.4M | 56% |
| Transportation | $45.6M | 44% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
